Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc.verified

PCSA

Price:

$0.2712

Market Cap:

$15.36M

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist that is in Phase 2A clinical trials for the treatment of gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia; PCS3117, a cytosine analog, wh...[Read more]

Industry

Biotechnology

IPO Date

2014-03-07

Stock Exchange

NASDAQ

Ticker

PCSA

The PE Ratio as of December 2025 (TTM) for Processa Pharmaceuticals, Inc. (PCSA) is -0.24

According to Processa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.24. This represents a change of 55.81% compared to the average of -0.15 of the last 4 quarters.

Processa Pharmaceuticals, Inc. (PCSA) Historical PE Ratio (quarterly & annually)

How has PCSA PE Ratio performed in the past?

The mean historical PE Ratio of Processa Pharmaceuticals, Inc. over the last ten years is -16.78. The current -0.24 PE Ratio has changed 43.01% with respect to the historical average. Over the past ten years (40 quarters), PCSA's PE Ratio was at its highest in in the June 2025 quarter at -0.00. The PE Ratio was at its lowest in in the December 2018 quarter at -57.16.

Quarterly (TTM)
Annual

Average

-16.78

Median

-5.00

Minimum

-77.26

Maximum

-0.19

Processa Pharmaceuticals, Inc. (PCSA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Processa Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 6.50%

Maximum Annual PE Ratio = -0.19

Minimum Annual Increase = -93.90%

Minimum Annual PE Ratio = -77.26

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.23-71.06%
2023-0.79-93.90%
2022-12.9296.73%
2021-6.5791.43%
2020-3.43-88.40%
2019-29.58-17.13%
2018-35.69-53.81%
2017-77.266.50%
2016-1.17524.24%
2015-0.19-69.50%

Processa Pharmaceuticals, Inc. (PCSA) Average PE Ratio

How has PCSA PE Ratio performed in the past?

The current PE Ratio of Processa Pharmaceuticals, Inc. (PCSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.65

5-year avg

-4.79

10-year avg

-16.78

Processa Pharmaceuticals, Inc. (PCSA) PE Ratio vs. Peers

How is PCSA’s PE Ratio compared to its peers?

Processa Pharmaceuticals, Inc.’s PE Ratio is greater than BriaCell Therapeutics Corp. (-2.37), greater than Curis, Inc. (-0.58), greater than Entero Therapeutics, Inc. (-0.25), greater than Leap Therapeutics, Inc. (-0.80), greater than Palisade Bio, Inc. (-1.20), greater than Hoth Therapeutics, Inc. (-1.54), greater than Moleculin Biotech, Inc. (-0.28), greater than Athira Pharma, Inc. (-0.41), greater than Allarity Therapeutics, Inc. (-1.12), greater than Citius Pharmaceuticals, Inc. (-0.34),

Build a custom stock screener for Processa Pharmaceuticals, Inc. (PCSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Processa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Processa Pharmaceuticals, Inc. (PCSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Processa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Processa Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Processa Pharmaceuticals, Inc. (PCSA)?

What is the highest PE Ratio for Processa Pharmaceuticals, Inc. (PCSA)?

What is the 3-year average PE Ratio for Processa Pharmaceuticals, Inc. (PCSA)?

What is the 5-year average PE Ratio for Processa Pharmaceuticals, Inc. (PCSA)?

How does the current PE Ratio for Processa Pharmaceuticals, Inc. (PCSA) compare to its historical average?